Dr. Mehmood H. Hashmi
Claim this profileCotton O'Neil Cancer Center / Stormont Vail Health
Studies Breast Cancer
Studies Lung Cancer
8 reported clinical trials
21 drugs studied
Area of expertise
1Breast Cancer
Stage IV
HER2 negative
Stage III
2Lung Cancer
Stage IV
Affiliated Hospitals
Clinical Trials Mehmood H. Hashmi is currently running
ONC-392 vs Chemotherapy
for Lung Cancer
This trial is testing gotistobart, a new drug that helps the immune system fight advanced lung cancer in patients who haven't responded to other treatments. It works by blocking a protein that allows cancer cells to hide from the immune system.
Recruiting2 awards Phase 310 criteria
Nivolumab + Ipilimumab + Sargramostim
for Advanced Melanoma
This phase II/III trial studies the side effects of nivolumab and ipilimumab when given together with or without sargramostim and to see how well they work in treating patients with stage III-IV melanoma that cannot be removed by surgery (unresectable) and that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Immunotherapy with monoclonal antibodies, such as ipilimumab and nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Colony-stimulating factors, such as sargramostim, may increase the production of white blood cells. It is not yet known whether nivolumab and ipilimumab are more effective with or without sargramostim in treating patients with melanoma.
Recruiting1 award Phase 2 & 323 criteria
More about Mehmood H. Hashmi
Clinical Trial Related1 year of experience running clinical trials · Led 8 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Mehmood H. Hashmi has experience with
- Docetaxel
- ONC-392
- Flutamide
- Goserelin Acetate
- Nilutamide
- External Beam Radiation Therapy
Breakdown of trials Mehmood H. Hashmi has run
Breast Cancer
Lung Cancer
Prostate Cancer
Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mehmood H. Hashmi specialize in?
Mehmood H. Hashmi focuses on Breast Cancer and Lung Cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are HER2 negative.
Is Mehmood H. Hashmi currently recruiting for clinical trials?
Yes, Mehmood H. Hashmi is currently recruiting for 5 clinical trials in Topeka Kansas. If you're interested in participating, you should apply.
Are there any treatments that Mehmood H. Hashmi has studied deeply?
Yes, Mehmood H. Hashmi has studied treatments such as Docetaxel, ONC-392, Flutamide.
What is the best way to schedule an appointment with Mehmood H. Hashmi?
Apply for one of the trials that Mehmood H. Hashmi is conducting.
What is the office address of Mehmood H. Hashmi?
The office of Mehmood H. Hashmi is located at: Cotton O'Neil Cancer Center / Stormont Vail Health, Topeka, Kansas 66606 United States. This is the address for their practice at the Cotton O'Neil Cancer Center / Stormont Vail Health.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.